Cryopreservation of hepatocytes: Impact of long-term storage and organ donor factors on cell quality for clinical applications

Cell Transplantation · Published 2026-04-01 · DOI 10.1177/09636897261417050

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1177/09636897261417050

Abstract

Liver transplantation is the only curative option for end-stage liver disease, but its applicability is limited by donor shortages. Hepatocyte transplantation offers a promising alternative, particularly for pediatric acute liver failure, yet its success relies on the availability of viable cells. Cryopreservation enables off-the-shelf use, though long-term storage may impair cell quality. This study investigates whether cryostorage duration, donor characteristics, and organ retrieval parameters affect the viability and functionality of cryopreserved primary human hepatocytes (PHHs). We conducted a retrospective analysis of 144 thawing events across 81 GMP-grade hepatocyte batches, cryopreserved for up to 14 years. Donor age ranged from 3 days to 70 years. Viability and functionality were assessed using MTT assays, albumin and urea secretion, and CYP450 activity. Linear regression was used to analyze correlations ( P < 0.05 considered significant). The cryopreservation duration had no significant impact on hepatocyte viability or function, confirming that clinical-grade PHHs can maintain quality for up to 14 years. However, donor age correlated negatively with post-thaw viability ( R 2 = 0.035, P = 0.029), yield ( R 2 = 0.039, P = 0.041), and metabolic activity ( R 2 = 0.278, P = 0.008), while showing a positive correlation with induced ethoxy resorufin O-demethylation (EROD) function ( R 2 = 0.432, P = 0.020). Donor body mass index (BMI) showed significant negative associations with viability ( R 2 = 0.075, P = 0.003), yield ( R 2 = 0.069, P = 0.011), and metabolic activity ( R 2 = 0.267, P = 0.019). Cold ischemia time (CIT) showed a weak negative correlation with viability ( R 2 = 0.151, P < 0.0001), particularly when CIT exceeded ~10 h and viability fell below 60%. Clinical-grade cryopreserved hepatocytes retain viability and function for over a decade. CIT, donor BMI, and age impacted post-thaw quality, while warm ischemia time (WIT), within our current criteria, and storage duration had minimal impact. These findings support refining donor selection to improve cryopreservation outcomes.

Abstract from DOAJ. Public domain (CC0 1.0).

Read the article at the publisher →

Publication details

Year
2026

Related articles